LevEllis, Inc. Launches PROVOQUE™
LevEllis, Inc., a forward-thinking skincare company, has officially introduced
PROVOQUE™, a groundbreaking regenerative serum. Established by the esteemed surgeon and molecular biologist, Dr. Laura Ellis, this innovative product aims to revolutionize the skincare landscape by incorporating advanced biotechnology to restore and rejuvenate skin.
Advanced Technology Behind PROVOQUE™
PROVOQUE™ features proprietary secretome technology sourced from human skin progenitor cells. This unique approach differs from typical skincare products that depend on isolated growth factors; instead, PROVOQUE™ offers a complete skin-specific secretome. This intricate, naturally balanced blend includes peptides, growth factors, cytokines, microRNA, exosomes, and various regenerative molecules designed to improve skin health.
Dr. Ellis expressed her enthusiasm in introducing what she terms a
next-generation advancement in regenerative aesthetics. She commented, “As regenerative medicine reshapes the future of aesthetics, PROVOQUE™ stands at the intersection of scientific evidence, innovation, and elegance.”
Pure and Effective Formulation
Distinguished by its clean formulation, PROVOQUE™ is devoid of fragrances, detergents, oils, or organic solvents. This deliberate choice preserves the biological integrity of the active components while minimizing potential irritants such as inflammatory cellular debris. This betterment in skincare suggests a significant leap towards the future of regenerative aesthetics.
Prominent stem cell researcher and inventor of the PROVOQUE™ technology, Dr. Hans Keirstead, noted, “What truly distinguishes PROVOQUE™ is that it is built upon skin-specific cellular science. The bioengineered skin progenitor cells yield a complete secretome — a robust blend of naturally occurring growth factors and exosomes.” He pointed out that dermatological studies published in the
Journal of Drugs in Dermatology indicate that users can notice healthier and smoother skin in as little as 14 days.
Collaboration with Experts
LevEllis, Inc. operates under the guidance of a respected scientific advisory board, including experts such as Dr. Julie Woodward, Dr. Jordan R. Plews, and Dr. Gabriel Nistor. Their extensive backgrounds in oculofacial surgery, dermatology, biotechnology, and regenerative medicine fortify LevEllis, Inc.'s commitment to scientific innovation in skincare.
Company Background and Future Aspirations
Co-founded by Dr. Laura Ellis, LevEllis, Inc. is focused on delivering scientifically validated and innovative skincare solutions. The company specializes in combining the expertise of seasoned professionals with commercialization specialists, aiming to bring exceptional products to market. Headquartered in Asheville, North Carolina, LevEllis, Inc. recently entered a licensing agreement with AIVITA Biomedical, granting them exclusive rights to market and distribute AIVITA's skincare formulations under the new PROVOQUE™ brand.
These formulations, previously marketed under the
Root of Skin™ label, showcase the company's dedication to high-quality skincare. AIVITA will continue to manufacture and supply the proprietary active ingredients from its certified facility in the USA.
For individuals eager to learn more about PROVOQUE™ and explore LevEllis, Inc.'s product lineup, they can visit
myprovoque.com or follow them on Instagram @myprovoque. This unveiling marks a significant step not only for LevEllis, Inc. but also for the entire skincare industry, driving a trend toward scientifically-backed and result-oriented products.